Ocular enucleation leads to NF-B activation in the superior colliculus. NF-B subunits p65 and p50 protein levels increased after visual system deafferentation. Dexamethasone was able to attenuate NF-B activation in the superior colliculus. a r t i c l e i n f o However, our knowledge of the molecular events resulting from eye enucleation in visual brain areas remains elusive. We characterized here the transcription nuclear factor kappa-B (NF-B) activation induced by ocular enucleation in the rat superior colliculus (SC). We also tested the effectiveness of the synthetic glucocorticoid dexamethasone in inhibiting its activation. Electrophoretic mobility shift assays to detect NF-B indicated that this transcription factor is activated in the SC from 1 h to day 15 postlesion. The expression of p65 and p50 proteins in the nuclear extracts was also increased. Dexamethasone treatment was able to significantly inhibit NF-B activation. These findings suggest that this transcriptional factor is importantly involved in the visual system short-term processes that ensue after retinal lesions in the adult brain.
Introduction
The nuclear factor kappa-B (NF-B) is a transcriptional regulator with a central role in inducing genes involved in neuronal plasticity, development, survival and inflammation. Five NF-B family members have been described in mammals: p50 (NF-B1), p65 (RelA), p52 (NF-B2), c-Rel and RelB. These NF-B family members are capable to form various homodimeric and heterodimeric complexes that can exert positive and negative effects on target gene transcription [9, 35] . As described in recent reviews [9, 19, 29] , activation of NF-B requires the phosphorylation, ubiquitination and subsequent degradation in the proteosome of its inhibitory subunit, known as IB (IB␣, IB␤, IB, IB BCL-3, IkBNS, p100, and p105, which are typified by the presence of multiple ankyrin repeat domains). The activated NF-B dimer translocates to the nucleus and binds with high affinity to DNA B sites with the 5 -GGGRNWYYCC-3 sequence in promoters and enhancers of target genes. Termination of the transcriptional response depends not only on resynthesis of typical IB proteins, but also on the removal of active NF-B dimers from the DNA [9, 35] .
NF-B influences the expression of a complex array of genes in the nervous system, including those coding for cytokines, such as tumor necrosis factor (TNF) and interleukin-6 [18, 30] , BCl family molecules [8] , cyclooxygenase-2 (COX-2) [11] , cell surface receptors [4] and antioxidant enzymes such as manganese superoxide dismutase [5] . The inducible form of nitric oxide synthase [18, 13] is also an important target gene for NF-B. Although the progress in understanding the mechanisms that stimulate NF-B activation has been undeniably remarkable in many regions of the nervous system, our knowledge of the roles of this transcription factor in the visual system remains underappreciated. Thus, considering the limited data available so far and the potential importance in understanding how this multifunctional transcription factor is involved in visual system physiological and pathological processes, the experiments described here were designed to directly test the effect of unilateral eye enucleation upon NF-B activation in the rat superior colliculus (SC). In addition, we investigated the effect of the synthetic glucocorticoid dexamethasone (DEX) on that phenomenon.
Materials and methods

Animals
Nine week-old male Wistar rats, weighing between 180 and 200 g, were used throughout this study. Animals were singly housed and maintained on a 12:12 h light/dark cycle. All procedures were approved by the Institutional Animal Care Committee of the Institute of Biomedical Sciences, University of São Paulo (protocol number 017/2007).
Unilateral enucleation
The animals were anesthetized with ketamine hydrochloride (5 mg/100 g of body weight, i.m.) and xylazine (1 mg/100 g of body weight, i.m.). Eye enucleation was performed by dissection of periorbital tissue with a scissor, resecting the optic nerves and completely removing the right eye. A piece of absorbable gelatin (Gelfoam, Upjohn, Kalamazoo, MO, USA) was placed inside the orbit for better healing, the eyelids were sutured to prevent bleeding, and the animals were returned to the animal facility. Animals used for electrophoretic mobility shift assay (EMSA) were sacrificed (n = 40) after different survival times, namely 1 h and 1, 7, 10, 15, and 30 days after unilateral enucleation. An additional group of rats (n = 25) were unilaterally enucleated and treated with dexamethasone (DEX) and their brains were also used in EMSA experiments. Intact animals were used as control groups.
Electrophoretic mobility shift assay to NF-ÄB consensus oligonucleotide
After the appropriate survival time, the animals were decapitated, the brains were removed and SC samples were immediately extracted under visual control after removal of the overlying cortical tissue. The SC samples approximately included the tissue in the dorsal brainstem from the bregma coordinates −5.52 to −7.57 [22] , and were frozen in liquid nitrogen and stored at −70 • C until use. Each SC was homogenized using a Dounce homogenizer in cold PBS supplemented with 0.5 mM DTT, 0.5 mM PMSF, 2 Lg/mLl leupeptin, 2 lg/mL antipain, and 3 mM sodium orthovanadate and centrifuged at 48 C for 30 s at 12,000 × g. Pellets were resuspended in lysis buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.1 mM EDTA, 0.5 mM PMSF, 2 g/mL leupeptin, 2 g/mL antipain, 3 mM sodium orthovanadate, 30 mM sodium fluoride, 20 mM sodium pyrophosphate) and incubated on ice for 10 min. After the addition of NP-40 (0.5%), samples were mixed and centrifuged for 30 s at 13,000 × g. Nuclei were resuspended in extraction buffer (20 mM HEPES, pH 7.9, 25% glycerol, 1.5 mM MgCl 2 , 300 mM NaCl, 0.25 mM EDTA, 0.5 mM PMSF, 2 g/mL leupeptin, 2 g/mL antipain), incubated for 20 min on ice and centrifuged for 20 min at 13,000 × g at 4 • C. The remaining supernatants containing nuclear proteins were stored at −80 • C. Protein concentration was determined using the BioRad protein reagent. EMSA for NF-B was performed using a gel shift assay kit from Promega [29] . NF-B double-stranded consensus oligonucleotide (5 -AGTTGAGGGGACTTTCCCAGGC-3 ) was end-labeled with ␥-32 P-ATP using T4 polynucleotide kinase. Unincorporated nucleotides were removed by passing the reaction mixture through a Sephadex G-25 spin column (Amersham-Pharmacia, Uppsala, Sweden). Purified 32 P-labeled probe (30,000 cpm) was incubated in 20 L with 5 g nuclear extracts in a binding reaction mixture containing 50 mM NaCl, 0.2 mM EDTA, 0.5 mM DTT, 4% glycerol, 10 mM Tris-HCl (pH 7.5) and 0.05 g poly(dI-dC) for 30 min at room temperature. DNA-protein complexes were separated by electrophoresis through a 6% non-denaturing acrylamide:bis-acrylamide (37.5:1) gel in 0.5× Tris-borate/EDTA (TBE) for 2 h at 150 V. Gels were vacuum-dried and analyzed by autoradiography. For competition experiments, NF-B and TFIID (5 -GCAGAGCATATAAGGTGAGGTAGGA-3 ) unlabeled double-stranded consensus oligonucleotide was included in 2-fold molar excess over the amount of 32 P-NF-B probe in order to detect specific and non-specific DNA-protein interactions, respectively. The composition of the complexes was determined by supershift assays; antibodies (1:10 dilution) against different NF-B subunits (p50 and p65) were added before the incubation of nuclear extracts with the labeled oligonucleotide. Autoradiograph quantification was performed with Image J (National Institutes of Health/USA).
Immunoblotting
In order to detect the presence of the p50 and p65 in nuclear extracts seven days after ocular enucleation, animals were decapitated, the brains were removed and the SC samples were quickly collected as described above. These samples were frozen in liquid nitrogen and stored at −70 • C until use. Nuclear extracts were prepared as described above. Seventy-five micrograms of total protein in Laemmli buffer were boiled for 5 min and separated by 8% acrylamide SDS gels (Bio-Rad, San Diego, CA, USA) at 25 mA and electrophoretically transferred to nitrocellulose membranes (Millipore, Billerica, MA, USA) at 100 V for 80 min using a Trans-Blot cell system (Bio-Rad, San Diego, CA, USA). The membranes were then blocked for 2 h at room temperature with phosphate buffered saline (PBS) containing 0.05% Tween-20 (TTBS) and 5% non-fat milk, and incubated overnight at 4 • C with antibodies against p50 and p65 (1:500; Santa Cruz, Biotechnology, CA, USA). The probed proteins were developed by using a chemiluminescent kit (ECL, Amersham Biosciences, EUA).
DEX treatment
The eye-enucleated animals received daily injections of DEX (1 mg/kg i.p.), a synthetic glucocorticoid with anti-inflammatory properties [1] , starting immediately after the lesion and for the next 2 consecutive days. DEX was dissolved in saline and thus the control groups received saline injections. Seven days after the lesion the brains were used for EMSA assays.
Determination of blood glucose
Since a single dose of DEX may significantly induce glucose intolerance [31] , hyperinsulinemia and hyperglycemia [24, 3] , tail blood samples of treated and non-treated rats were collected for measurement of blood glucose levels using a glucometer (One-touch Ultra, Johnsons and Johnsons, Milpitas, CA, USA).
Statistical analysis
Values are expressed as means ± S.E.M. Statistical comparisons were performed by one-way ANOVA, followed by Tukey's multiple comparison tests. Values of p ≤ 0.05 were considered significant. Data from the contralateral side of the brain to the removed eye were always compared to data obtained from intact animals. The number of rats (n) used in each group is referred to in the legends.
Results
Electrophoretic mobility shift assay to NF-ÄB consensus oligonucleotide
As evaluated by EMSA, ocular enucleation significantly increased NF-B DNA binding activity in nuclear extracts of the contralateral SC from 1 h to day 15 (ca. 216-254%) postlesion, however 30 days postlesion there was no significant activation of NF-B (Fig. 1A and B) . Supershift analysis indicated that the p65 subunit antibody shifted DNA/protein complex interactions found in SC nuclear extracts. In contrast, p50 subunit antibody did not affect DNA-protein complex. These results suggest that the p65 subunit was possibly the major NF-B component that is present in nuclear extracts of SC samples (Fig. 1D) . The NF-B/DNA complex was displaced by an excess of unlabeled NF-B, but not by TFIID double stranded oligonucleotide consensus sequence, demonstrating the specificity of NF-B/DNA binding interaction of this complex (Fig. 1D) . DEX treatment was able to inhibit the NF-B activation by 44% (Fig. 2) . The presence of the p65 and p50 subunits and the effect of ocular enucleation on their levels were revealed by means of immunoblotting assays (C, n = 3). Competition studies (D, n = 4) were performed using nuclear extracts from SC 7 days postlesion in the absence or presence of unlabeled (NF-B consensus sequence 5-fold molar excess) or non-specific oligonucleotide (TFIID consensus sequence 20-fold molar excess), as indicated. Supershift assays were also performed in the absence or presence of antibodies against subunits p50 and p65. NS represents non-specific binding. The localization of the probe is also indicated.
Immunoblotting
Immunoblotting data revealed the presence of both p65 and p50 subunits in SC nuclear extracts. It was also possible to detect the increased expression of both proteins 7 days postlesion. The basal p50 protein expression seems to be much smaller than p65 expression (Fig. 1C) . These results suggest that the NF-B complex in the deafferented SC is also composed of p50 subunits.
Determination of blood glucose
Our results indicated that the blood glucose levels (n = 6-7 samples in each case) were not significantly altered after DEX treatment (85.6 ± 2.2, 82.4 ± 1.8, 87 ± 2.5, 84.9 ± 1.9 mg/dL for control, control + DEX, deafferented and deafferented + DEX, respectively).
Discussion
The rodent visual system provides a suitable model to study the impact of the retinal afferents on the functional organization of the central visual areas. Experimental manipulation of retinal outputs, such as crush and section of the optic nerve, leads to degeneration of retinal ganglion cells [21] and to morphological alterations in the visual centers of the brain. The subcortical visual system is comprised of a large number of retinorecipient nuclei, including the lateral geniculate complex, the pretectal nuclei, the superior colliculus (SC), the accessory optic nuclei and hypothalamic areas [2] . In rats, the SC represents the major primary retinal projection area, receiving approximately 65% of the contralateral retinal ganglion cell projections [32] . This represents a major reason why several studies have addressed the electrophysiological, morphological and biochemical changes in the SC induced by unilateral eye enucleation [15, 28] . However, our knowledge of the molecular events resulting from eye enucleation in the SC remains elusive.
As evaluated by EMSA, the present study demonstrates that eye enucleation leads to a transient NF-B activation in the SC. In agreement with our results, there is an extensive literature regarding NF-B activation in several regions of the nervous system. For instance, NF-B activity is increased after seizure activity [7] , in a rat model of amyloid-beta-induced Alzheimer's disease [38] and after lesions of the spinal cord [17] . However, only a limited number of reports have addressed the role of this transcription factor in the visual system. A study carried out in monkeys revealed that monocular enucleation does not change p65 expression in nuclear fractions of primary visual cortex. This observation is also supported by the absence of degradation of the NF-B cytoplasmic anchoring protein IB␣ [14] . In contrast, a recent report has also described that retinal ganglion cells under hypoxia exhibited increased NF-B activation and IB phosphorylation/degradation [33] . The functional significance of the NF-B activation in the SC after retinal removal is still unclear. As this transcription factor acts broadly influencing gene expression events that impact cell survival, it is likely to contribute to the intense plastic activity occurring after such lesions, even in adult animals, a hypothesis that remains yet to be directly tested.
Among a variety of different stimuli, it is particularly important to mention glutamate as well as reactive oxygen species (ROS) as relevant inducers of NF-B activation [6] , since they have been described in retinorecipient structures after retinal lesions [20, 23, 10] . Although this study did not include an attempt to establish a direct relationship between glutamate and ROS on NF-B activation, these data may lead to the speculation that both could be involved in NF-B activation after retinal removal. Although supershift assay analysis indicated that p65 homodimer was possibly the major DNA-protein complex present in nuclear extracts of SC samples, we further characterize the expression of NF-B protein subunits by means of immunoblotting. Analysis of nuclear extracts showed that both p65 and p50 protein levels markedly increased seven days after the lesion, suggesting that the NF-B complex is mainly composed of p65 subunits, although p50 is also present [12] .
DEX is a synthetic glucocorticoid with anti-inflammatory properties [1] . The mechanistic basis of the anti-inflammatory actions of glucocorticoids remains poorly understood, but accumulating evidence suggests that these effects largely result from inhibition of signal-dependent transcription factors that mediate inflammatory programs of gene activation such as those involving NF-B [16] . Although most of these studies have been limited to inflammatory cells such as macrophages and lymphocytes in vitro, the ability of DEX in suppress NF-B activation is considered to be a predominant mechanism by which it exerts its anti-inflammatory effects [36] . A proposed mechanism involves IB inhibitory protein transcription induction, which reduces the amount of NF-B that translocates to the nucleus [26] . In the present study, when administered daily over the course of 3 days, DEX was able to significantly inhibit NF-B activation. Similarly, other studies have demonstrated that DEX treatment significantly attenuates LPS-induced NF-B DNAbinding activity in the rat cortex [37] and experimentally induced seizures in the rat cortex and hippocampus [34] . Furthermore, DEX can selectively inhibit p65 subunit expression when administered before LPS and kainate in rat striatal primary neuronal cultures [27] . It is noteworthy that the DEX doses administered in the present study were not able to alter glucose levels. Similarly, 12 days of DEX treatment (1 mg/kg) did not alter the plasma glucose levels in rats [25] .
The findings of the present study indicate that the removal of retinal ganglion cell input leads to a transient NF-B activation into SC, and therefore to a neuroinflammatory process. This was confirmed by the fact that systemic injections of DEX effectively blocked NF-B activation. Immunoblotting and EMSA data suggest that the NF-B complex in the deafferented SC is mainly composed of p65 subunits, although p50 is also present. In summary, these results are likely to integrate with several other advances in the knowledge of adult visual system damage, regeneration and structural remodeling induced by deafferentation.
